The Air We Could Measure

On September 22, 2021, the World Health Organization announced new global air-quality guidelines, reflecting evidence that pollution damages health at lower concentrations than previously understood. Following a systematic review of evidence accumulated since its 2005 global update, WHO lowered almost all its recommended guideline levels.

The atmosphere had not suddenly acquired a new trick. Our account of what it was doing to people had become harder to dismiss.

The recommendations covered fine and coarse particulate matter—PM2.5 and PM10—along with ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. WHO said their development drew on six systematic reviews considering more than 500 papers. This was not a new instrument detecting a previously invisible substance. It was a reassessment of how much harm familiar pollutants could cause.

The size labels conceal a consequential journey. PM10 refers to particles no larger than 10 micrometres in diameter; PM2.5 to those no larger than 2.5. Both can penetrate deep into the lungs, WHO explained, while PM2.5 can also enter the bloodstream. Something small enough to escape ordinary notice can become a cardiovascular problem. Biology is not obliged to respect the distinction between “out there” and “in here.”

WHO estimated that air-pollution exposure caused seven million premature deaths each year. That was an estimate of an enormous health burden, not a count of death certificates bearing one convenient label. The agency described effects ranging from reduced lung growth and aggravated asthma in children to heart disease and stroke in adults.

Nor was the problem waiting for stricter guidance to become widespread. According to the release, more than 90% of the global population in 2019 lived in areas exceeding the 2005 guideline for long-term PM2.5 exposure. The old recommendation was already beyond the air most people lived with.

Here the announcement’s precision met its limit: WHO’s guidelines were not legally binding. They were evidence-informed tools for legislation and policy, not evidence that any government had adopted, enforced or achieved them. A recommendation can make an obligation clearer without giving anyone the power to fulfil it.

WHO acknowledged that difficulty by proposing interim targets: steps toward the recommended levels that could deliver meaningful health benefits along the way. This matters. An ambitious endpoint need not make partial improvement worthless. Equally, naming a first step does not make it a sufficient destination.

The agency also described an unequal burden, with the greatest attributable disease burden from ambient air pollution in low- and middle-income countries. Its global announcement cannot tell us which particular community had effective monitoring, enforcement or political leverage. Those questions require local evidence, not an uplifting extrapolation from a press release.

For coherenceism, the useful turn is from recognizing a shared medium to examining who bears its costs. Shared air does not mean equal exposure, and a cleaner statistical average would not alone establish that the least-protected people had been heard. The ethical task is to connect what can be measured with accountable decisions about reducing harm.

The September 22 update offered a firmer basis for that work, not its completion. Knowledge became more demanding because the evidence did. There is something quietly hopeful in a standard willing to change when bodies reveal what an older standard missed.

Breathing is compulsory. Accepting avoidable harm should not be.